Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141207 |
| CAS No | NA |
| Mol.F. | C21H21N9O6 : 2(Na) |
| Mol.Wt. | 495.5 : 2(23.0) |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141208 |
| CAS No | NA |
| Mol.F. | C17H23N3O6 |
| Mol.Wt. | 365.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141209 |
| CAS No | NA |
| Mol.F. | C17H22N4O7 |
| Mol.Wt. | 394.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141210 |
| CAS No | NA |
| Mol.F. | C13H14N4O7 |
| Mol.Wt. | 338.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141211 |
| CAS No | NA |
| Mol.F. | C20H21N9O6 |
| Mol.Wt. | 483.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141212 |
| CAS No | NA |
| Mol.F. | C20H21N9O6 |
| Mol.Wt. | 483.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141213 |
| CAS No | NA |
| Mol.F. | C11H16N2O |
| Mol.Wt. | 192.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141214 |
| CAS No | 871884-77-4 |
| Mol.F. | C18H22N2O |
| Mol.Wt. | 282.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141215 |
| CAS No | NA |
| Mol.F. | C6H3ClN4O |
| Mol.Wt. | 182.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141216 |
| CAS No | NA |
| Mol.F. | C3H2BrN3O |
| Mol.Wt. | 176.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141217 |
| CAS No | NA |
| Mol.F. | C14H12N8O |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141218 |
| CAS No | NA |
| Mol.F. | C17H18N8O3S |
| Mol.Wt. | 414.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141219 |
| CAS No | NA |
| Mol.F. | C6H4N4O2 |
| Mol.Wt. | 164.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141220 |
| CAS No | NA |
| Mol.F. | C10H15BN2O3 |
| Mol.Wt. | 222.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141221 |
| CAS No | NA |
| Mol.F. | C15H20N6O2Si |
| Mol.Wt. | 344.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141222 |
| CAS No | NA |
| Mol.F. | C17H19N7O2 |
| Mol.Wt. | 353.4 |
| INV STATUS | CUSTOM SYNTHESIS |